Editorial: Non-insulin pharmacotherapies for the treatment of type 2 diabetes and obesity - old and new players. [PDF]
Front Clin Diabetes HealthcPatoulias D, Muzurović E, Rizzo M.
europepmc +1 more source
Comparable glycemic outcomes with insulin glargine and insulin degludec during exercise in adolescents with type 1 diabetes using a standardized management protocol. [PDF]
Diabetes Obes MetabRabbone I +10 more
europepmc +1 more source
Total costs of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: register-based observational study in clinical practice [PDF]
, 2015 core +1 more source
Comparative Effectiveness of Switching From First-Generation Basal Insulins to Either Glargine 300 U/mL or Degludec 100 U/mL in Children and Adolescents With Type 1 Diabetes: Results From the ISPED CARD Clinical Registry. [PDF]
Pediatr DiabetesRabbone I +8 more
europepmc +1 more source
iGlarLixi: A titrateable fixed-ratio combination of basal insulin + GLP-1 receptor agonist-An effective type 2 diabetes treatment option in China. [PDF]
Diabetes Obes MetabYu M.
europepmc +1 more source
Detemir plus aspart and glulisine induced lipoatrophy: 2015 literature review and report of a new case [PDF]
, 2015 core +1 more source
Emerging perspectives on once-weekly insulins in type 1 and type 2 diabetes: a mini-review. [PDF]
Front Endocrinol (Lausanne)Denimal D.
europepmc +1 more source
iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats. [PDF]
J Feline Med SurgTaylor S +7 more
europepmc +1 more source
Acute Pancreatitis and Diabetic Ketoacidosis: Special Considerations in Diagnosis and Management. [PDF]
Case Rep EndocrinolBabiker A +6 more
europepmc +1 more source